- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
All News
Bariatric Surgery Lowers Mortality, Risk of Events in Patients with Diabetes and Obesity
April 26, 2021
A retrospective analysis of matched cohorts has led investigators to suggest bariatric surgery should be viewed as a first-line treatment for the management of obesity in patients with type 2 diabetes.
Endocrine Month in Review: April 2021
April 24, 2021
April's month in review features stories related to new diabetes medications, stem cells, disparities in care of women, and how exposure to endocrine-disrupting chemicals in pregnancy can impact mental health following delivery. Check back in during the last weekend of each month for the next Endocrine Month in Review.
Diets Characterized by Pro-Inflammatory Foods Linked to Low Testosterone in Men
April 23, 2021
An analysis of dietary patterns from more than 4000 men in NHANES suggests a diet with a greater intake of inflammatory foods was associated with a nearly 30% increase in odds of developing testosterone deficiency.
Migraine Prior to Menopause Could Signal Increased Hypertension Risk
April 22, 2021
Data from a cohort of more than 50k French women indicates the presence of migraine prior to entering menopause was associated with a nearly 30% greater risk of developing hypertension.
Research Identifies Genetic Variants that Might Predispose Pregnant Women to Rare Heart Condition
April 21, 2021
An analysis of more than 400 women with peripartum cardiomyopathy is providing insight into a group of genetic variants that could help identify patients who are genetically predisposed to the rare cardiovascular condition.
Gender-Affirming Hormone Therapy Linked to Blood Pressure Changes in Transgender Individuals
April 20, 2021
The largest study of its kind is providing insight related to changes in blood pressure seen among transgender patients initiating gender-affirming hormone therapy.
FDA Makes Historic First Approving NEXTSTELLIS, an Oral Contraceptive Containing E4
April 20, 2021
The approval, which was awarded to Mayne Pharma, makes NEXTSTELLIS the first and only contraceptive pill containing E4, a natural occurring estrogen to receive approval from the FDA.
ACC/AHA 2017 Exercise Recommendations May Not Be Enough to Prevent Hypertension
April 19, 2021
An analysis of the CARDIA study by investigators at UCSF suggests a recommendation of 5 hours of physical activity per week may be more appropriate than the current ACC/AHA recommendation for reducing the risk of hypertension.
Dapagliflozin Effective for Reducing CV Risk in Diabetes, Irrespective of Kidney Function
April 16, 2021
TIMI Group investigators found the effects of dapagliflozin on cardiovascular risk in patients with diabetes were comparable in those with markers of CKD and those without markers of CKD at baseline.
Race, Gender, & Income Influence Access to SGLT2 Inhibitors Among US Patients
April 15, 2021
Using data from nearly 1 million patients with type 2 diabetes in a commercial database, investigators provide a comprehensive of the impact race/ethnicity, gender, and income can have on the likelihood of receiving a prescription for SGLT2 inhibitors.